Funding for research posts to search for MND treatments

two researchers in a darkened room looking at a large projection of a brain

Apr 2018: We announce funding for two new postdoctoral laboratory scientists who will work on screening for new drug leads for MND.

Almost £400,000 in new MND research funding has been committed over the next three years by the Scottish Government and the UK Dementia Research Institute (DRI) at the University of Edinburgh. The new postdocs will work in the lab of Euan MacDonald Centre Director Professor Siddharthan Chandran.

The scientists will look at chemical compounds that have the potential to be developed into drugs to treat MND. These would then go through a process that could include clinical trials to test their safety and effectiveness.

We want to ensure that people living with neurological conditions such as motor neurone disease, which is diagnosed in around 200 Scots annually, have access to the best possible care and support across the country. This partnership will allow us to build on our previous MND research funding, which includes a number of PhD studentships totalling almost half a million pounds over five years.

Shona RobisonHealth Secretary

Investment in MND care, clinical research and training represents a huge and growing shift in momentum over recent years. We are delighted to be partnering the Chief Scientist Office in this venture to identify and develop new treatments for MND clinical trials and experimental medicine in Scotland, and we are honoured to have the chance to add to this momentum.

Giles HardinghamCity of Edinburgh Professor of Pharmacology and Associate Director, UK DRI at the University of Edinburgh

Related links

Professor Siddharthan Chandran's profile

UK DRI at the University of Edinburgh

SPRINT-MND/MS PhD studentships

This article was published on: Monday, April 16, 2018